Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Shields

Showing results (61-70 of 186) with videos related to

Pageof 19
Sort By:
Molecular Imaging and Biology|October 11, 2003
Kinetics of 3'-deoxy-3'-[F-18]fluorothymidine uptake and retention in dogsAnthony F Shields, John R Grierson, Otto Muzik, et al.
AJR. American Journal of Roentgenology|March 23, 2007
The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence developmentMatthew J Lindsay, Barry A Siegel, Sean R Tunis, et al.
Theranostics|November 22, 2017
Liposomal <sup>64</sup>Cu-PET Imaging of Anti-VEGF Drug Effects on Liposomal Delivery to Colon Cancer XenograftsStephanie J Blocker, Kirk A Douglas, Lisa Anne Polin, et al.
American Journal of Clinical Oncology|June 5, 2010
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experienceNazik Hammad, Lance K Heilbrun, Sachin Gupta, et al.
American Journal of Clinical Oncology|April 2, 2005
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primaryBasil F El-Rayes, Anthony F Shields, Mark Zalupski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Dawei Liu, et al.
Cancer|November 19, 2008
The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Anthony F Shields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2007
The National Oncologic PET Registry (NOPR): design and analysis planBruce E Hillner, Dawei Liu, R Edward Coleman, et al.
Molecular Imaging and Biology|March 15, 2017
A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [<sup>18</sup>F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate CancerUlka N Vaishampayan, Omid S Tehrani, Jawana M Lawhorn-Crews, et al.
ISRN Oncology|October 30, 2013
Radiographic parameters in predicting outcome of patients with hepatocellular carcinoma treated with yttrium-90 microsphere radioembolizationMohamed E Salem, Nitin Jain, Gregory Dyson, et al.
Pageof 19

Showing results (61-70 of 186) with videos related to

Sort By:
Pageof 19
Molecular Imaging and Biology|October 11, 2003
Kinetics of 3'-deoxy-3'-[F-18]fluorothymidine uptake and retention in dogsAnthony F Shields, John R Grierson, Otto Muzik, et al.
AJR. American Journal of Roentgenology|March 23, 2007
The National Oncologic PET Registry: expanded medicare coverage for PET under coverage with evidence developmentMatthew J Lindsay, Barry A Siegel, Sean R Tunis, et al.
Theranostics|November 22, 2017
Liposomal <sup>64</sup>Cu-PET Imaging of Anti-VEGF Drug Effects on Liposomal Delivery to Colon Cancer XenograftsStephanie J Blocker, Kirk A Douglas, Lisa Anne Polin, et al.
American Journal of Clinical Oncology|June 5, 2010
Squamous cell cancer of the anal canal in HIV-infected patients receiving highly active antiretroviral therapy: a single institution experienceNazik Hammad, Lance K Heilbrun, Sachin Gupta, et al.
American Journal of Clinical Oncology|April 2, 2005
A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primaryBasil F El-Rayes, Anthony F Shields, Mark Zalupski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 26, 2008
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Dawei Liu, et al.
Cancer|November 19, 2008
The impact of positron emission tomography (PET) on expected management during cancer treatment: findings of the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Anthony F Shields, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2007
The National Oncologic PET Registry (NOPR): design and analysis planBruce E Hillner, Dawei Liu, R Edward Coleman, et al.
Molecular Imaging and Biology|March 15, 2017
A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [<sup>18</sup>F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate CancerUlka N Vaishampayan, Omid S Tehrani, Jawana M Lawhorn-Crews, et al.
ISRN Oncology|October 30, 2013
Radiographic parameters in predicting outcome of patients with hepatocellular carcinoma treated with yttrium-90 microsphere radioembolizationMohamed E Salem, Nitin Jain, Gregory Dyson, et al.
Pageof 19